Prostamax — EU research guide.
Prostamax is a Khavinson-series peptide bioregulator derived from prostate gland tissue, proposed to support prostate cell function and regulate local inflammatory responses. It is one of several organ-specific cytomedin-style bioregulators in the same research family as Chitomur and Testagen.
What is Prostamax?
Prostamax is a Khavinson-series peptide bioregulator derived from prostate gland tissue, proposed to support prostate cell function and regulate local inflammatory responses. It is one of several organ-specific cytomedin-style bioregulators in the same research family as Chitomur and Testagen.
What does the research show?
Available research is limited to small Eastern European cohort studies looking at prostate volume and urinary flow markers in aging models. No independently replicated controlled human trials are publicly available as of mid-2026.
EU legal status
Not approved as a medicine anywhere in the EU. Sold by a small number of specialist research vendors for laboratory research only.
Molecular information
Pharmacokinetics
Prostamax is not yet in our price comparison
We expand EU supplier coverage every month.